H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 83 Citations 19,859 272 World Ranking 8402 National Ranking 99

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Endocrinology

Internal medicine, Surgery, Endocrinology, Vitamin D and neurology and Risk factor are his primary areas of study. His Internal medicine study is mostly concerned with Odds ratio, Randomized controlled trial, Hazard ratio, Osteoporosis and Confidence interval. The concepts of his Surgery study are interwoven with issues in Muscular dystrophy, Hip fracture, Epidemiology and Confounding.

Parathyroid hormone, Phosphorus metabolism, Urology and Urinary calcium is closely connected to Calcium metabolism in his research, which is encompassed under the umbrella topic of Endocrinology. His Vitamin D and neurology research incorporates elements of Vitamin, Obesity, Insulin resistance and ACE inhibitor. His Risk factor research is multidisciplinary, incorporating perspectives in Diabetes mellitus, Type 1 diabetes, Type 2 diabetes, Spinal muscular atrophy type II and Insulin.

His most cited work include:

  • Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. (454 citations)
  • Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk (406 citations)
  • Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research (331 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Endocrinology, Vitamin D and neurology, Hypoparathyroidism and Osteoporosis. Parathyroid hormone, Bone remodeling, Bone mineral, Calcium metabolism and Primary hyperparathyroidism are among the areas of Internal medicine where he concentrates his study. His Endocrinology research incorporates themes from Secondary hyperparathyroidism, Calcium and Urology.

As a member of one scientific family, he mostly works in the field of Vitamin D and neurology, focusing on Randomized controlled trial and, on occasion, Vitamin d supplementation and Physical therapy. His Osteoporosis research is multidisciplinary, relying on both Surgery, Raloxifene and Case-control study. His research investigates the link between Surgery and topics such as Odds ratio that cross with problems in Confidence interval.

He most often published in these fields:

  • Internal medicine (78.36%)
  • Endocrinology (49.60%)
  • Vitamin D and neurology (26.39%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (78.36%)
  • Hypoparathyroidism (19.00%)
  • Endocrinology (49.60%)

In recent papers he was focusing on the following fields of study:

Lars Rejnmark mainly focuses on Internal medicine, Hypoparathyroidism, Endocrinology, Pediatrics and In patient. His research is interdisciplinary, bridging the disciplines of Gastroenterology and Internal medicine. His research on Hypoparathyroidism also deals with topics like

  • Retrospective cohort study that intertwine with fields like Hazard ratio and Rheumatology,
  • Creatinine, Kidney and Hypercalciuria most often made with reference to Renal function,
  • Urology which is related to area like Bone remodeling.

His Endocrinology study combines topics in areas such as Calcium metabolism, Pregnancy and Quality of life. His Pediatrics study incorporates themes from Adult patients, Disease, Nephrocalcinosis, Type 2 diabetes and Cohort. The concepts of his Vitamin D and neurology study are interwoven with issues in Vitamin and Obstetrics.

Between 2018 and 2021, his most popular works were:

  • Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. (86 citations)
  • Unmet therapeutic, educational and scientific needs in parathyroid disorders: Consensus Statement from the first European Society of Endocrinology Workshop (PARAT) (23 citations)
  • Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus (22 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Endocrinology

His primary areas of study are Internal medicine, Endocrinology, Vitamin D and neurology, Osteoporosis and Primary hyperparathyroidism. Internal medicine and In patient are two areas of study in which Lars Rejnmark engages in interdisciplinary work. His studies in Endocrinology integrate themes in fields like Calcium metabolism and Secondary hyperparathyroidism, Parathyroid hormone.

The various areas that Lars Rejnmark examines in his Vitamin D and neurology study include Vitamin, Randomized controlled trial, Large cohort and Oncology. He interconnects Zoledronic acid and Urology in the investigation of issues within Osteoporosis. Lars Rejnmark has included themes like Parathyroidectomy, Hyperparathyroidism and Quality of life in his Primary hyperparathyroidism study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.

Louise Lind Schierbeck;Lars Rejnmark;Charlotte Landbo Tofteng;Lis Stilgren.
BMJ (2012)

684 Citations

Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk

P. Vestergaard;L. Rejnmark;L. Mosekilde.
Diabetologia (2005)

620 Citations

Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

B Abrahamsen;T Masud;A Avenell;F Anderson.
BMJ (2010)

481 Citations

Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research

John P Bilezikian;Aliya Khan;John T Potts;Maria Luisa Brandi.
Journal of Bone and Mineral Research (2011)

474 Citations

Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.

P. Vestergaard;L. Rejnmark;L. Mosekilde.
Calcified Tissue International (2006)

469 Citations

Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications.

P. Vestergaard;L. Rejnmark;L. Mosekilde.
Osteoporosis International (2007)

336 Citations

Association of vitamin D status with arterial blood pressure and hypertension risk: A mendelian randomisation study

Karani S Vimaleswaran;Karani S Vimaleswaran;Alana Cavadino;Diane J Berry;Rolf Jorde.
The Lancet Diabetes & Endocrinology (2014)

333 Citations

Fracture rates and risk factors for fractures in patients with spinal cord injury.

P Vestergaard;K Krogh;L Rejnmark;L Mosekilde.
Spinal Cord (1998)

306 Citations

Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Shonni J. Silverberg;Bart L. Clarke;Munro Peacock;Francisco Bandeira.
The Journal of Clinical Endocrinology and Metabolism (2014)

306 Citations

Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus

A A Khan;D A Hanley;R. Rizzoli;J Bollerslev.
Osteoporosis International (2017)

297 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Lars Rejnmark

Peter Vestergaard

Peter Vestergaard

Steno Diabetes Center

Publications: 98

Cyrus Cooper

Cyrus Cooper

Southampton General Hospital

Publications: 91

John P. Bilezikian

John P. Bilezikian

Columbia University

Publications: 77

JoAnn E. Manson

JoAnn E. Manson

Harvard Medical School

Publications: 49

Ian R. Reid

Ian R. Reid

University of Auckland

Publications: 49

William D. Leslie

William D. Leslie

University of Manitoba

Publications: 46

Piet Geusens

Piet Geusens

Maastricht University

Publications: 44

René Rizzoli

René Rizzoli

Geneva College

Publications: 42

Kim Brixen

Kim Brixen

University of Southern Denmark

Publications: 41

Stefan Pilz

Stefan Pilz

Medical University of Graz

Publications: 41

John A. Kanis

John A. Kanis

University of Sheffield

Publications: 38

Maria Luisa Brandi

Maria Luisa Brandi

University of Florence

Publications: 37

John A. Eisman

John A. Eisman

Garvan Institute of Medical Research

Publications: 32

Jonathan D. Adachi

Jonathan D. Adachi

McMaster University

Publications: 32

Rolf Jorde

Rolf Jorde

University of Tromsø - The Arctic University of Norway

Publications: 31

Something went wrong. Please try again later.